Dae-Woong Cho
Chief Executive Officer at CELLIVERY THERAPEUTICS, INC.
Net worth: 26 M $ as of 31/03/2023
Dae-Woong Cho active positions
| Companies | Position | Start | End |
|---|---|---|---|
| CELLIVERY THERAPEUTICS, INC. | Director/Board Member | 28/08/2014 | - |
| Chief Executive Officer | 28/08/2014 | - | |
| Chief Tech/Sci/R&D Officer | 28/08/2014 | - | |
| Founder | 14/03/2014 | - |
Career history of Dae-Woong Cho
Former positions of Dae-Woong Cho
| Companies | Position | Start | End |
|---|---|---|---|
ProCell Therapeutics, Inc.
 ProCell Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology ProCell Therapeutics, Inc. develops protein-based therapeutics. It handles the research and development of biotherapeutics capable of entering cells through proprietary Macromolecule Intracellcellular Transduction Technologies (MITT) using a line-up of Macromolecule Transduction Domain (MTD). The company was founded on December 12, 2005 and is headquartered in Seoul, South Korea. | Founder | 20/12/2005 | - |
| President | 09/04/2010 | - | |
| Chonnam National University | Corporate Officer/Principal | - | - |
| YUHAN CORPORATION | Corporate Officer/Principal | - | - |
GenoCheck Co., Ltd.
 GenoCheck Co., Ltd. Medical SpecialtiesHealth Technology GenoCheck Co., Ltd. is a holding company, which conducts research in biotechnology and offers products and services related to genes. Its activities include exploring and testing of genes related to human diseases, developing diagnostic deoxyribonucleic acid (DNA) chip and new drugs. The firm's products include microarray, ribonucleic acid stabilization solution, and DNA extraction kit. The company was founded on May 1, 2000 and is headquartered in Seoul, South Korea. | Corporate Officer/Principal | - | - |
| Vanderbilt University | Corporate Officer/Principal | - | - |
Training of Dae-Woong Cho
| Vanderbilt University | Doctorate Degree |
| Hanyang University | Graduate Degree |
Statistics
International
| South Korea | 7 |
| United States | 2 |
Operational
| Corporate Officer/Principal | 4 |
| Founder | 2 |
| Director/Board Member | 1 |
Sectoral
| Health Technology | 5 |
| Consumer Services | 4 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 2 |
|---|---|
| CELLIVERY THERAPEUTICS, INC. | Health Technology |
| YUHAN CORPORATION | Health Technology |
| Private companies | 2 |
|---|---|
GenoCheck Co., Ltd.
GenoCheck Co., Ltd. Medical SpecialtiesHealth Technology GenoCheck Co., Ltd. is a holding company, which conducts research in biotechnology and offers products and services related to genes. Its activities include exploring and testing of genes related to human diseases, developing diagnostic deoxyribonucleic acid (DNA) chip and new drugs. The firm's products include microarray, ribonucleic acid stabilization solution, and DNA extraction kit. The company was founded on May 1, 2000 and is headquartered in Seoul, South Korea. | Health Technology |
ProCell Therapeutics, Inc.
ProCell Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology ProCell Therapeutics, Inc. develops protein-based therapeutics. It handles the research and development of biotherapeutics capable of entering cells through proprietary Macromolecule Intracellcellular Transduction Technologies (MITT) using a line-up of Macromolecule Transduction Domain (MTD). The company was founded on December 12, 2005 and is headquartered in Seoul, South Korea. | Health Technology |
- Stock Market
- Insiders
- Dae-Woong Cho
- Experience
